Journal article
PHARMACOGENETICS AND THE NEONATAL ABSTINENCE SYNDROME FOLLOWING MATERNAL ANTIDEPRESSANT USE IN PREGNANCY
Abstract
Objectives Depression and anxiety are common, occurring in up to 20% of pregnancies. Many women will be treated with antidepressant medication during pregnancy, but there is ongoing concern about possible withdrawal effects in the newborn, referred to as the Neonatal Abstinence Syndrome (NAS). The reason why some infants remain resilient while other are affected has not been elucidated. The objective of this study was to examine whether genetic …
Authors
Shea A; Murphy K; Dalfen A; Snelgrove J; Wang D
Journal
Journal of Obstetrics and Gynaecology Canada, Vol. 41, No. 5,
Publisher
Elsevier
Publication Date
May 2019
DOI
10.1016/j.jogc.2019.02.233
ISSN
1701-2163